Literature DB >> 8086332

Alcoholic cardiomyopathy.

L Fabrizio1, T J Regan.   

Abstract

Clinical observations over the past two decades have pointed to the relationship between heart disease and alcohol abuse, usually without evident malnutrition or cirrhosis. While the prevalence of heart failure in the alcoholic population is now known, subclinical abnormalities of left ventricular function in noncardiac alcoholics who were normotensive have a high prevalence with or without some degree of ventricular hypertrophy by echocardiogram. This is frequently a diastolic rather than systolic abnormality. Congestive cardiomyopathy is not infrequently associated with high diastolic arterial blood pressures. Intoxication itself may contribute to blood pressure elevation. Angina pectoris in the absence of significant coronary disease is another presentation. Although the history may not be readily obtained, the major diagnostic feature in this entity is the history of ethanol ingestion in intoxicating amounts for at least 10 years, often marked by periods of spree drinking. While the course of congestive cardiomyopathy may be progressively downhill in individuals who continue to be actively alcoholic after the onset of heart failure, in one series one third of the patients became abstinent. These patients had a 4 year mortality that was persistently one-sixth of the alcoholic group. Management of heart failure is traditional in these patients. Atrial arrhythmias have been shown to occur during the early ethanol withdrawal phase in patients without other clinical evidence of heart disease. Sudden death in a segment of the alcoholic population is considered arrhythmia related and is commonly associated with cigarette use. Identification of the addicted individual is the essential element to management.

Entities:  

Mesh:

Year:  1994        PMID: 8086332     DOI: 10.1007/bf00877094

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  24 in total

1.  Risk factors in alcoholic cardiomyopathy.

Authors:  E L Kinney; R J Wright; J W Caldwell
Journal:  Angiology       Date:  1989-04       Impact factor: 3.619

2.  Alcoholic cardiomyopathy managed with prolonged bed rest.

Authors:  C D McDonald; G E Burch; J J Walsh
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

3.  The increasing mortality attributed to cirrhosis and fatty liver, in Baltimore (1957-1966).

Authors:  K Kramer; L Kuller; R Fisher
Journal:  Ann Intern Med       Date:  1968-08       Impact factor: 25.391

4.  Progression of myocardial abnormalities in experimental alcoholism.

Authors:  G Thomas; B Haider; H A Oldewurtel; M M Lyons; C K Yeh; T J Regan
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

5.  Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders.

Authors:  P O Ettinger; C F Wu; C De La Cruz; A B Weisse; S S Ahmed; T J Regan
Journal:  Am Heart J       Date:  1978-05       Impact factor: 4.749

6.  Marked spontaneous improvement in ejection fraction in patients with congestive heart failure.

Authors:  G S Francis; T H Johnson; S Ziesche; M Berg; P Boosalis; J N Cohn
Journal:  Am J Med       Date:  1990-09       Impact factor: 4.965

7.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

8.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

9.  Sudden death and hepatic fatty metamorphosis. A North Carolina survey.

Authors:  B Randall
Journal:  JAMA       Date:  1980-05-02       Impact factor: 56.272

10.  Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics.

Authors:  F Schwarz; G Mall; H Zebe; E Schmitzer; J Manthey; H Scheurlen; W Kübler
Journal:  Circulation       Date:  1984-12       Impact factor: 29.690

View more
  5 in total

Review 1.  Prevention of relapse in patients with congestive heart failure: the role of precipitating factors.

Authors:  J Feenstra; D E Grobbee; F A Jonkman; A W Hoes; B H Stricker
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

2.  Rapid fatty acid ethyl ester synthesis by porcine myocardium upon ethanol infusion into the left anterior descending coronary artery.

Authors:  Danita M Yoerger; Catherine A Best; Brendan M McQuillan; Gregory E Supple; J Luis Guererro; Joanne E Cluette-Brown; Ali Hasaba; Michael H Picard; James R Stone; Michael Laposata
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

3.  Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

Authors:  Roland Jahns; Valérie Boivin; Lutz Hein; Sven Triebel; Christiane E Angermann; Georg Ertl; Martin J Lohse
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 4.  Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking.

Authors:  Christine E Skotzko; Alina Vrinceanu; Lynnette Krueger; Ronald Freudenberger
Journal:  Heart Fail Rev       Date:  2007-11-22       Impact factor: 4.214

Review 5.  Alcoholic cardiomyopathy : The result of dosage and individual predisposition.

Authors:  B Maisch
Journal:  Herz       Date:  2016-09       Impact factor: 1.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.